Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, Switzerland.
Am J Med. 2011 Sep;124(9):841-51.e2. doi: 10.1016/j.amjmed.2011.04.024.
Evidence from individual trials comparing Mediterranean to low-fat diets to modify cardiovascular risk factors remains preliminary.
We systematically searched MEDLINE, EMBASE, Biosis, Web of Science, and the Cochrane Central Register of Controlled Trials from their inception until January 2011, as well as contacted experts in the field, to identify randomized controlled trials comparing Mediterranean to low-fat diets in overweight/obese individuals, with a minimum follow-up of 6 months, reporting intention-to-treat data on cardiovascular risk factors. Two authors independently assessed trial eligibility and quality.
We identified 6 trials, including 2650 individuals (50% women) fulfilling our inclusion criteria. Mean age of enrolled patients ranged from 35 to 68 years, mean body mass index from 29 to 35 kg/m(2). After 2 years of follow-up, individuals assigned to a Mediterranean diet had more favorable changes in weighted mean differences of body weight (-2.2 kg; 95% confidence interval [CI], -3.9 to -0.6), body mass index (-0.6 kg/m(2); 95% CI, -1 to -0.1), systolic blood pressure (-1.7 mm Hg; 95% CI, -3.3 to -0.05), diastolic blood pressure (-1.5 mm Hg; 95% CI, -2.1 to -0.8), fasting plasma glucose (-3.8 mg/dL, 95% CI, -7 to -0.6), total cholesterol (-7.4 mg/dL; 95% CI, -10.3 to -4.4), and high-sensitivity C-reactive protein (-1.0 mg/L; 95% CI, -1.5 to -0.5). The observed heterogeneity across individual trials could, by and large, be eliminated by restricting analyses to trials with balanced co-interventions or trials with restriction of daily calorie intake in both diet groups.
Mediterranean diets appear to be more effective than low-fat diets in inducing clinically relevant long-term changes in cardiovascular risk factors and inflammatory markers.
比较地中海饮食和低脂饮食对心血管风险因素的影响的个体试验证据仍然是初步的。
我们系统地检索了 MEDLINE、EMBASE、Biosis、Web of Science 和 Cochrane 对照试验中心注册库,从其建立到 2011 年 1 月,以及联系该领域的专家,以确定比较超重/肥胖人群中地中海饮食和低脂饮食的随机对照试验,随访时间至少 6 个月,报告心血管风险因素的意向治疗数据。两位作者独立评估了试验的入选标准和质量。
我们确定了 6 项试验,共纳入 2650 名符合入选标准的患者(50%为女性)。纳入患者的平均年龄为 35-68 岁,平均体重指数为 29-35kg/m2。随访 2 年后,接受地中海饮食的患者体重(-2.2kg;95%置信区间[CI],-3.9 至-0.6)、体重指数(-0.6kg/m2;95%CI,-1.0 至-0.1)、收缩压(-1.7mmHg;95%CI,-3.3 至-0.05)、舒张压(-1.5mmHg;95%CI,-2.1 至-0.8)、空腹血糖(-3.8mg/dL;95%CI,-7 至-0.6)、总胆固醇(-7.4mg/dL;95%CI,-10.3 至-4.4)和高敏 C 反应蛋白(-1.0mg/L;95%CI,-1.5 至-0.5)的变化更有利。通过将分析仅限于具有均衡的联合干预或在两组饮食中限制每日热量摄入的试验,基本上可以消除个体试验之间的异质性。
与低脂饮食相比,地中海饮食在诱导心血管风险因素和炎症标志物的长期临床相关变化方面似乎更有效。